Source:http://linkedlifedata.com/resource/pubmed/id/10070844
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1999-4-23
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1071-3581
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-90
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10070844-Animals,
pubmed-meshheading:10070844-Antibodies, Monoclonal,
pubmed-meshheading:10070844-Arteriosclerosis,
pubmed-meshheading:10070844-Humans,
pubmed-meshheading:10070844-Lipoproteins, LDL,
pubmed-meshheading:10070844-Oxidation-Reduction,
pubmed-meshheading:10070844-Radioimmunodetection
|
pubmed:articleTitle |
Strategic targeting of atherosclerotic lesions.
|
pubmed:publicationType |
Editorial,
Comment
|